Phase I trial of three-weekly Docetaxel, Carboplatin and oral lenalidomide (Revlimid®) in patients with advanced solid tumors
S. Kalmadi, M. Davis, A. Dowlati, S. O’Keefe, M. Cline-Burkhardt, R. J. Pelley, E. Borden, R. Dreicer, R. Bukowski, T. MekhailVolume:
25
Language:
english
Pages:
6
DOI:
10.1007/s10637-006-9025-4
Date:
June, 2007
File:
PDF, 203 KB
english, 2007